Furthermore, experimental ATRX knockout in four telomerase-positive, ALT-negative glioma lines showed that only two lines exhibited ALT features post-ATRX loss, highlighting the need for additional factors beyond ATRX in fully establishing ALT activity [31]. The gene discussed is ATRX; the disease is central nervous system cancer.